Profile
Michael A. Martino was the founder of Arzeda Corp., a company founded in 2008, where he held the title of President & Chief Executive Officer from 2008 to 2011.
He is currently the CEO, Chief Financial Officer, Secretary & Director at Ampio Pharmaceuticals, Inc., the Chief Executive Officer & Director at HemaFlo Therapeutics, Inc., a Director at Ambit Biosciences Corp., and a Director at CaraVan Biologix.
Mr. Martino's former positions include being the President & Chief Executive Officer of Sonus Pharmaceuticals, Inc. from 1998 to 2008, the President, Chief Executive Officer & Director of Ambit Biosciences Corp.
from 2011 to 2014, and the SVP-Innovation, Business Development & Strategy at CareFusion Corp.
He also served as a Director at OncoGenex Pharmaceuticals, Inc., Excision BioTherapeutics, Inc., and the Technology Alliance.
Additionally, Mr. Martino was the Chairman of the Washington Biotechnology & Biomedical Association and held the position of VP-Strategic Planning & Corporate Development at Mallinckrodt Medical, Inc. from 1983 to 1998.
He served as a Trustee at Roanoke College from 2016 to 2020.
Mr. Martino obtained an undergraduate degree from Roanoke College and an MBA from Virginia Polytechnic Institute & State University.
Michael Martino active positions
| Companies | Position | Start |
|---|---|---|
| AMBIT BIOSCIENCES CORP | Director/Board Member | 2021-10-12 |
| AMPIO PHARMACEUTICALS, INC. | Chief Executive Officer | 2021-11-21 |
HemaFlo Therapeutics, Inc.
HemaFlo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | - |
CaraVan Biologix | Director/Board Member | - |
Former positions of Michael Martino
| Companies | Position | End |
|---|---|---|
Roanoke College
Roanoke College Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | 2019-12-31 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Director/Board Member | 2010-06-07 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and related therapies | President | 2008-08-21 |
Mallinckrodt Medical, Inc.
Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets healthcare products | Corporate Officer/Principal | 1997-12-31 |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Director/Board Member | - |
Training of Michael Martino
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and related therapies | Health Technology |
Ambit Biosciences Corp.
Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
CareFusion Corp.
CareFusion Corp. Medical SpecialtiesHealth Technology Manufactures and distributes medical supplies | Health Technology |
Mallinckrodt Medical, Inc.
Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets healthcare products | Health Technology |
Roanoke College
Roanoke College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technology Alliance
Technology Alliance Miscellaneous Commercial ServicesCommercial Services Provides education, research and entrepreneurship through programs, events, data analysis and policy activities | Commercial Services |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Arzeda Corp.
Arzeda Corp. BiotechnologyHealth Technology Operates as a synthetic biology company | Health Technology |
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immuno modulatory therapies for the treatment of pain from osteoarthritis | Health Technology |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Health Technology |
HemaFlo Therapeutics, Inc.
HemaFlo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
CaraVan Biologix |
- Stock Market
- Insiders
- Michael Martino
















